Biblio Discovery — Demo Discovery Service

5 hasil untuk "Maxime Samson"

Menampilkan 1–5 · 0,43 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients

    Clémentine Estève; Maxime Samson; Alexandre Guilhem dkk.

    PLOS ONE, Vol. 12 No. 10 · 2017 · Inggris · PLOS Scopus

    Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety in daily…

  2. Artikel Jurnal Teks lengkap

    Venous thromboembolic events during warm autoimmune hemolytic anemia

    Sylvain Audia; Benoit Bach; Maxime Samson dkk.

    PLOS ONE, Vol. 13 No. 11 · 2018 · Inggris · PLOS Scopus

    Thrombotic manifestations are a hallmark of many auto-immune diseases (AID), specially of warm autoimmune hemolytic anemia (wAIHA), as 15 to 33% of adults with wAIHA experience venous thromboembolic events (VTE). However, beyond the presence of positive antiphospholipid antibodies and splenectomy…

  3. Artikel Jurnal Teks lengkap

    Full-field optical coherence tomography for the diagnosis of giant cell arteritis

    Thomas Maldiney; Hélène Greigert; Laurent Martin dkk.

    PLOS ONE, Vol. 15 No. 8 · 2020 · Inggris · PLOS Scopus

    Histopathological examination of temporal artery biopsy (TAB) remains the gold standard for the diagnosis of giant cell arteritis (GCA) but is associated with essential limitations that emphasize the need for an upgraded pathological process. This study pioneered the use of full-field optical…

  4. Artikel Jurnal Teks lengkap

    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

    Mikael Ebbo; Aurélie Grados; Maxime Samson dkk.

    PLOS ONE, Vol. 12 No. 9 · 2017 · Inggris · PLOS Scopus

    Objectives: To assess efficacy and safety of rituximab (RTX) as induction therapy, maintenance of remission and treatment of relapses in a cohort of IgG4-related disease (IgG4-RD) patients. Methods: Nationwide retrospective multicenter study of IgG4-RD patients treated with at least one course of…